Status:
UNKNOWN
Cannabis for Opioid Substitution Trial
Lead Sponsor:
Cannabis Research Associates
Conditions:
Pain Syndrome
Opioid Use
Eligibility:
All Genders
25+ years
Brief Summary
The purpose of this study is to define common strains of cannabis that adult chronic cancer and non-cancer pain syndrome patients are using as a replacement for opioids (narcotics). Identified strains...
Detailed Description
The search for safer alternatives to opioids for treating chronic cancer and non-cancer pain syndromes currently is an important initiative. Cannabis Research Associates (CRA) has been commissioned by...
Eligibility Criteria
Inclusion
- Adult patients aged \> 25 years-CPSO Policy states that physicians cannot prescribe medical cannabis to persons under the age of 25 unless all other conventional therapies have failed. Furthermore, there is evidence to support that cannabis use in younger persons can have lasting effects since the brain is still developing (Wier K, 2015).
- English-speaking, or with the assistance of a family member/friend that can interpret English for the patient.
- Qualifying medical diagnosis for appropriate use of medical cannabis by a licensed physician.
- Current medical cannabis use to treat chronic cancer and non-cancer pain syndromes.
- Current or past use of prescription opioids to treat chronic cancer and non-cancer pain syndromes.
Exclusion
- 1\. Patients taking medical cannabis for reasons other than chronic cancer and non-cancer pain syndromes
Key Trial Info
Start Date :
October 10 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2019
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT03859089
Start Date
October 10 2017
End Date
October 31 2019
Last Update
March 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Synergy Health Services Inc.
Hamilton, Ontario, Canada